Sorafenib in advanced hepatocellular carcinoma: a further step toward personalized therapy of liver cancer
- PMID: 19324105
- DOI: 10.1053/j.gastro.2009.03.010
Sorafenib in advanced hepatocellular carcinoma: a further step toward personalized therapy of liver cancer
Comment on
-
Sorafenib in advanced hepatocellular carcinoma.N Engl J Med. 2008 Jul 24;359(4):378-90. doi: 10.1056/NEJMoa0708857. N Engl J Med. 2008. PMID: 18650514 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
